Posted in | News | Biofuels

Oxford Catalysts Presented with Environmental Excellence Award at CleanEquity Monaco 2010

The Oxford Catalysts Group was presented with an award for Excellence in the Field of Environmental Technology Commercialisation by HSH Prince Albert II of Monaco, at the CleanEquity Monaco 2010 conference. This invitation-only clean technology conference was attended by 36 next-generation technology companies, which presented to over 250 delegates from four continents.

The award recognises the Group's progress in bringing its clean fuels technology to the brink of commercialisation. The winning technology comprises the Group's microchannel reactor technology which is used for both steam methane reforming (SMR) and the Fischer-Tropsch (FT) processes. Applications include small scale distributed production of next-generation biofuels, and use as a tool to reduce gas flaring via gas-to-liquids (GTL). Diesel and jet fuels produced as a result offer significant environmental benefits over equivalent products sourced from fossil fuels.

Roy Lipski, CEO of the Oxford Catalysts Group said:

"CleanEquity Monaco is one of the leading industry conferences. With only three awards presented at the event, this is a substantial endorsement for Oxford Catalysts and its technologies."

Mungo Park, Chairman of Innovator Capital, the conference host, said:

"Oxford Catalysts progressing to win in this category demonstrates a depth and breadth in management, competitive advantage and potential CO2 impact that has been recognised by successive judges. Its smaller scale gas-to-liquids technology has tremendous potential"

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.